Showing results (91-100 of 170) with videos related to
Sort By:
Pageof 17
Journal of Medical Virology|June 10, 2025
Inhibition of Influenza Entry by Organosilicon CompoundsAleksandar Antanasijevic, Nicholas J Haferman, Amir Shimon, et al.Journal of Virology|June 14, 2003
Kinetic analysis of binding interaction between the subgroup A Rous sarcoma virus glycoprotein SU and its cognate receptor Tva: calcium is not required for ligand bindingXuemei Yu, Qing-Yin Wang, Ying Guo, et al.Scientific Reports|September 8, 2016
Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in miceHongbo Shen, Feifei Wang, Gucheng Zeng, et al.Journal of Biomolecular Screening|January 15, 2016
A High-Throughput Screening Platform Targeting PDLIM5 for Pulmonary HypertensionHan Cheng, Tianji Chen, Merve Tor, et al.Frontiers in Immunology|July 26, 2021
Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1Jing Yang, Edith A Perez, Changchun Hou, et al.Viruses|March 28, 2018
Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry InhibitorQinghua Cui, Ruikun Du, Manu Anantpadma, et al.Frontiers in Microbiology|April 8, 2020
Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase InhibitorsPing Li, Ruikun Du, Yanyan Wang, et al.ACS Pharmacology & Translational Science|December 14, 2023
Identification of the Imidazo[1,2-a]pyrazine Derivative A4 as a Potential Influenza Virus Nucleoprotein InhibitorPing Li, Han Ju, Yihong Xing, et al.Cell & Bioscience|February 28, 2021
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteasesZinuo Chen, Qinghua Cui, Laura Cooper, et al.Journal of Ethnopharmacology|June 19, 2023
Qingjin Huatan decoction protects mice against influenza a virus pneumonia via the chemokine signaling pathwaysMiaomiao Liu, Fangshu Zhao, Jinke Xu, et al.Pageof 17